Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

A new generation of companies is eyeing the existing, sizeable hair loss market, hoping that better formulations and new ...

(Reuters) -Telehealth company Mangoceuticals said on Thursday it has partnered with Eli Lilly and Novo Nordisk to sell the ...

Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

On Wednesday, Lilly said Zepbound would be sold directly in Walmart pharmacies for $349 to $499 a month. Next year, Lilly is ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

The recent jump in Irish exports was driven almost entirely by pharmaceutical giant Eli Lilly and its two bestselling ...

The US Food and Drug Administration (FDA) has approved Linzess (linaclotide) as the first treatment for children living with ...